AIMCA
ICPT

Alberta Investment Management Corp (AIMCo)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,432
Closed -$355K – 1319
2023
Q1 		$355K Buy
26,432
+7,231
+38% +$125K ﹤0.01% 1046
2022
Q4 		$238K Buy
+19,201
New +$272K ﹤0.01% 994

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ICPT Position: Q2 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 26,432 shares — an estimated $355K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ICPT in Q4 2022 and held it in 2 quarters. The position peaked at $355K in Q1 2023. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 26,432 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $355K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2022 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Intercept Pharmaceuticals, Inc. position peaked at $355K in Q1 2023.
  • 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2023, filed 14 Aug 2023.